For these reasons, we assessed the relative clinical validity by time since cough onset of CDC’s array of pertussis diagnostics by evaluating the sensitivities and specificities of culture, multi-target RT-PCR, and IgG-PT serology for the diagnosis of B. pertussis infection. This evidence concerns the gene F2 and pertussis.